InvestorsHub Logo
Followers 12
Posts 170
Boards Moderated 0
Alias Born 11/08/2012

Re: None

Saturday, 06/28/2014 2:57:58 AM

Saturday, June 28, 2014 2:57:58 AM

Post# of 158400
11JUN PR -- Significance -- weekend research

Ok, so I caught part of the NBCNews special with Meredith Vierira "A Leap of Faith" discussion on tracheal stem cell organ transplants, w/ Dr. Paolo Macchiarini, tonight. Recommended viewing, not sure if it will be re-aired yet. Basically, details the start of stem cell organ transplant in humans, the technology is here and now.

http://www.nbcnews.com/feature/a-leap-of-faith/leap-faith-desperate-patients-look-lab-grown-organs-n142036

After viewing, I re-read the 11JUN PR and have a better understanding for what Dr. Min is attempting to accomplish with Dcellvax. Targeted immune suppression. Right now, the difficulty with stem cell organ transplants; patients' bodies do not always accept the transplant and require immune suppressant drugs that impact the entire immune system leading to complications. Dcellvax, through preliminary experimentation, is exhibiting to work cooperatively with stem cell organ transplants. Dcellvax is an application that will allow stem cell organ transplants to be accepted by the patients body! Once proven effective and safe, it is intended to be a "global" application for all stem cell organ transplants.

From Dr. Hawkins TV special a couple months ago and Dr. Macchiarini's work, the momentum and technology is there to grow organs from a patient's stem cells...and it looks like the transplant applications are about to catch up in a very large way. All these hospitals/surgeons/regenerative med. Pharma Companies/etc...involved in stem cell organ transplants for patients with exceptional need medical conditions, will need dcellvax application for surgery recovery and to increase their transplant acceptance, according to the research paper.

TO solidify Min's research, in my mind, a couple more months to file an IND is more than welcomed. We are no longer talking about an application to immune stimulate against breast cancer, this is an application that will be sought out by the entire regenerative medicine community. Landmark/game changing potential.

Why anyone would not be accumulating at these levels for the time we have left, is beyond me, heck, I would be knocking on Koos' door to privately purchase Regen shares if you missed the divy.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.